Market revenue in 2024 | USD 22.7 million |
Market revenue in 2030 | USD 44.7 million |
Growth rate | 12% (CAGR from 2024 to 2030) |
Largest segment | Services |
Fastest growing segment | Services |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Oligonucleotides, Equipment/Synthesizer, Reagents, Services |
Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, GE HealthCare Technologies Inc Common Stock, Agilent Technologies, Kaneka Corp, Heritage Global Inc, Twist Bioscience Corp, Bio-Synthesis, Biolegio |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to oligonucleotide synthesis market will help companies and investors design strategic landscapes.
Services was the largest segment with a revenue share of 37.44% in 2024. Horizon Databook has segmented the Saudi Arabia oligonucleotide synthesis market based on oligonucleotides, equipment/synthesizer, reagents, services covering the revenue growth of each sub-segment from 2018 to 2030.
Saudi Arabia has been investing in biotechnology and life sciences initiatives, including R&D. The growth of these initiatives is expected to drive the demand for oligonucleotide synthesis in various applications, such as genomics, diagnostics, and therapeutics.
The government initiated Saudi Human Genome Program in 2018 to develop the field of diagnostics and prevent genetic diseases. In addition, extensive research studies involving sequencing can help expand the usage rate of advanced DNA sequencing techniques in this country.
According to the Centre for Arab Genomic Studies, Saudi Arabia has a high burden of genetic diseases, primarily due to consanguinity. The number of cancer cases and deaths has also increased in recent years in the country. As per the GLOBOCAN data, in 2020, around 27,885 new cancer cases were diagnosed in Saudi Arabia and around 13,069 people succumbed to cancer.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia oligonucleotide synthesis market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia oligonucleotide synthesis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account